CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.66B, above the global median of $1.18B
- FinancialsAltman Z-Score 6.1: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
159.65BINR1.66B · vs all stocks (USD)
Trailing P/E
107.53xvs Medical Instruments & Supplies peers
Revenue (TTM)
22.07BINR229.96M · vs all stocks (USD)
Profit Margin
6.72%vs Medical Instruments & Supplies peers
52-Week Change
-0.74%vs all stocks
Market Capitalization
159.65BINR1.66B · vs all stocks (USD)
Enterprise Value
167.17BINR1.74B · vs all stocks (USD)
Trailing P/E
107.53xvs Medical Instruments & Supplies peers
Forward P/E
59.51xvs Medical Instruments & Supplies peers
PEG Ratio
2.13xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
7.18xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
7.82xvs Medical Instruments & Supplies peers
Enterprise to Revenue
7.58xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
33.28xvs Medical Instruments & Supplies peers
Gross Margin
64.43%vs Medical Instruments & Supplies peers
Profit Margin
6.72%vs Medical Instruments & Supplies peers
Operating Margin
15.00%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
3.38%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
6.28%vs Medical Instruments & Supplies peers
Revenue (TTM)
22.07BINR229.96M · vs all stocks (USD)
Revenue per Share (TTM)
69.76INRUpdated Sep 29, 2026Quarterly Revenue Growth
26.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
9.62BINR100.28M · vs all stocks (USD)
EBITDA (TTM)
6.05BINR63.05M · vs all stocks (USD)
Net Income (TTM)
1.48BINR15.46M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
50.50%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
5.19BINR54.08M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.33BINR13.88M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00INRUpdated Sep 29, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
942.40MINRFY2026 · Mar 31, 2026Revenue
20.80BINRFY2026 · Mar 31, 2026Cost of Goods Sold
7.52BINRFY2026 · Mar 31, 2026Gross Profit
13.28BINRFY2026 · Mar 31, 2026Operating Income
2.93BINR30.57M · vs all stocks (USD)
Pre-tax Income
2.49BINRFY2026 · Mar 31, 2026Income Tax Expense
805.00MINRFY2026 · Mar 31, 2026Net Income
1.68BINRFY2026 · Mar 31, 2026EBIT
3.39BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
6.14BINRFY2026 · Mar 31, 2026Other Operating Expenses
3.55BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
904.60MINRFY2026 · Mar 31, 2026Minority Interests (P&L)
-349.50MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
2.57BINRFY2026 · Mar 31, 2026Free Cash Flow
2.56BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
905.50MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
2.49BINRFY2026 · Mar 31, 2026Stock-based Compensation
73.90MINRFY2026 · Mar 31, 2026Other Non-cash Items
776.10MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-541.20MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-221.90MINRFY2026 · Mar 31, 2026Capital Expenditures
8.60MINRFY2026 · Mar 31, 2026Net Acquisitions
-913.40MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-904.80MINRFY2026 · Mar 31, 2026Long-term Debt Issuance
0.00INRFY2026 · Mar 31, 2026Long-term Debt Payments
-896.00MINRFY2026 · Mar 31, 2026Common Dividends Paid
-10.90MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-793.20MINRFY2026 · Mar 31, 2026Shares Outstanding
317.03MSharesUpdated Sep 29, 2026Float Shares
120.97MSharesUpdated Sep 29, 2026% Held by Insiders
62.84%vs all stocks
% Held by Institutions
27.18%vs all stocks
Total Cash (MRQ)
2.84BINR29.57M · vs all stocks (USD)
Total Cash per Share (MRQ)
8.96INRUpdated Sep 29, 2026Total Debt (MRQ)
10.66BINR111.11M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5030xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.24xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
63.93INRUpdated Sep 29, 2026Total Assets
39.42BINR410.77M · vs all stocks (USD)
Total Current Assets
5.73BINRFY2026 · Mar 31, 2026Total Liabilities
18.22BINRFY2026 · Mar 31, 2026Total Non-current Assets
33.69BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
13.61BINRFY2026 · Mar 31, 2026Total Current Liabilities
4.61BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
905.50MINRFY2026 · Mar 31, 2026Other Short-term Investments
2.04BINRFY2026 · Mar 31, 2026Accounts Receivable
1.61BINRFY2026 · Mar 31, 2026Inventory
940.30MINRFY2026 · Mar 31, 2026Accounts Payable
1.49BINRFY2026 · Mar 31, 2026Short-term Debt
1.15BINRFY2026 · Mar 31, 2026Other Current Liabilities
287.90MINRFY2026 · Mar 31, 2026Long-term Debt
9.51BINRFY2026 · Mar 31, 2026Common Stock (Book)
316.80MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
21.20BINR220.89M · vs all stocks (USD)
52-Week Low
401.00INRUpdated Sep 29, 202652-Week High
568.00INRUpdated Sep 29, 202652-Week Change
-0.74%vs all stocks
50-Day MA
502.92INRUpdated Sep 29, 2026200-Day MA
470.75INRUpdated Sep 29, 2026Avg 10-Day Volume
235.04KSharesUpdated Sep 29, 2026Avg 30-Day Volume
400.21KSharesUpdated Sep 29, 2026Diluted EPS (TTM)
4.65INRUpdated Sep 29, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.64Profit Margin: 0.07
Financial Health
Altman Z-Score 6.1: safe zoneNotable
Altman Z-Score: 6.10
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.66B, above the global median of $1.18BNotable
Market cap (USD): 1,663,758,387.029Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Jilin Sino-Microelectronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Alliance Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
JSW Cement Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hankook & Company Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu New Energy Development Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Freewon China Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Paradeep Phosphates Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Tongyu Heavy Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Taiyo Holdings Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
SL Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Staidson (Beijing) Biopharmaceuticals Co., Ltd.
1 interpretationIndustry-Benchmarked ROA and Margin Elevated
Yamaichi Electronics Co., Ltd.
1 interpretationIndustry-Benchmarked ROA and Margin Elevated
Ningbo Deye Technology Co., Ltd.
1 interpretationIndustry-Benchmarked ROA and Margin Elevated